Reuters — Eli Lilly + Co.’s Elanco Animal Health unit expects its initial public offering to raise up to US$1.45 billion, betting on increased appetite among investors for animal health companies. The IPO of 62.9 million shares is expected to be priced between $20-$23 per unit, with the company having a valuation of about $8 […] Read more
